Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis

PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Ophthalmol
Main Authors: de la Sen-Corcuera, Borja, Montero-Iruzubieta, Jesús, Sánchez-Ávila, Ronald M, Orive, Gorka, Anitua, Eduardo, Caro-Magdaleno, Manuel, Merayo-Lloves, Jesús
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7306461/
https://ncbi.nlm.nih.gov/pubmed/32606577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S252253
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki